Developer of biotechnology designed to create new therapies to treat Lyme disease. The company develops novel therapeutics and narrow-spectrum for the treatment of tick-borne diseases offers to advance microbiome-targeted therapeutics and diagnostics for the treatment of rare infectious diseases, enabling patients to get a new form of treatment with no side effects.

Developer of human recombinant decorin core protein as a topical anti-scarring therapy designed to treat Dystrophic Epidermolysis Bullosa, a devastating , genetic, skin blistering disease. The company’s therapy is developing a gel formulation of human recombinant Decorin, an engineered form of the natural anti-scarring protein, that binds collagen and facilitates the proper development, maintenance, and…

Developing a drug to burn calories and improve metabolism

Operator of a clinical biotechnology company intended to develop new solutions to treat diabetes. The company specializes in the research and development of early-stage drug discovery of therapeutics that would improve pancreatic endocrine cell health, enabling the healthcare industry to implement advances in pancreatic stem cell differentiation and the development of human cellular models for…

Royal DSM is a purpose-led global science-based company in Nutrition, Health and Sustainable Living.

Developer of a fermentation system designed to create natural medicines. The company’s system uses genetics and computing enabled deciphering technology to produce co-evolved and bio-inspired cannabinoids medicines and nutraceuticals in genetics, synthetic biology, and data science, enabling physicians to understand and harvest biology into bio-inspired medicines and nutraceuticals for gene synthesis.

Sustainably producing the world’s first beanless coffee.